IMPORTANCE Delta hemoglobin (ΔHb), defined as the difference between the preoperative hemoglobin (Hb) level and the nadir Hb level during a patient's hospitalization, may be associated with adverse outcomes even if the absolute level of Hb remains greater than the transfusion threshold of 7 g/dL.
edge, the ideal "trigger" for transfusion has not been determined. In patients who do not present with signs and symptoms of anemia or hemodynamic instability, laboratory indicators, such as Hb level, typically drive practice patterns around transfusion use. In the past decade, the introduction of transfusion triggers and "targets" to assess the initiation and end point of transfusion based on Hb concentrations has aided in preventing the overuse of PRBC. 5, 6 Our group and others have previously demonstrated that the use of a restrictive transfusion trigger resulted in equivalent or improved postoperative morbidity compared with the liberal use of blood products.
7-11
The use of Hb triggers and targets do not, however, take into account individual variability or the possibility that a subset of patients may experience inadequate tissue oxygenation even when the Hb concentration is higher than 7 or 8 g/dL.
Aside from the use of Hb triggers, some investigators have suggested that the percentage of change in the Hb level should also be used to guide transfusion practices and help dictate when it is appropriate to administer blood products to surgical patients. For example, among patients undergoing cardiac surgery, a large percentage change or "delta" in the Hb level (ΔHb) of 50% or greater was associated with worse outcomes, even when the absolute Hb level remained greater than the commonly used threshold for PRBC transfusions (<7-8g/dL).
12 Given this fact, PRBC transfusions may be indicated in certain situations based on the absolute ΔHb level as opposed to the nadir Hb level. In a cohort of patients undergoing cardiac surgery, patients who had a decrease of 50% or more in the Hb level from baseline but did not reach the transfusion trigger threshold of 7 g/dL had a greater risk of in-hospital mortality, stroke, myocardial infarction, and renal failure. 13 To our knowledge, the effect of ΔHb has never been examined in a cohort of patients undergoing noncardiac operations. As such, the objective of this study was to define how the ΔHb level, relative to the Hb trigger, was associated with outcomes among patients who underwent pancreatic, hepatic, or colorectal resection at a tertiary academic hospital. Specifically, we sought to characterize how the ΔHb and nadir Hb levels (Hb level, <7 g/dL) correlated with overall morbidity, as well as ischemic-specific complications, in patients who underwent major gastrointestinal surgery.
Method

Patient Selection
Patients who underwent a pancreatic, hepatobiliary, or colorectal operation at Johns Hopkins Hospital from January 1, 2010 , through April 30, 2014 , were identified using the appropriate International Classification of Diseases, Ninth Revision (ICD-9), procedure codes. A retrospective review of prospectively collected data was performed; the study and data analysis took place from January 22 through February 20, 2015. The Johns Hopkins Institutional Review Board approved this study, and a patient consent waiver was signed. Standard data on demographic, clinicopathological, and therapy-related variables were collected. The presence of coexisting medical conditions was classified based on the American Society of Anesthesiologists (ASA) Physical Status classification and Charlson comorbidity index scores. Patients' ICD-9 diagnosis codes at discharge were used to identify in-hospital perioperative complications. 7, 8 Cerebrovascular accidents, transient ischemic attack, and myocardial infarction were defined as ischemic adverse events.
13
To avoid a bias of preexisting anemia or polycythemia, we excluded patients with abnormal Hb levels and included patients with preoperative Hb levels of 12.0 to 16.0 g/dL in women and 13.0 to 18.0 g/dL in men.
14
Data Collection
Perioperative transfusion and Hb levels were obtained through the IMPACT Online Blood Management Business Intelligence Portal (Hemonetics) that integrates patients' and cases' clinicopathological, operative, and laboratory data. Data on the location of the transfusion (eg, operative room, intensive care unit, or department) were not available. All data in the system are collected prospectively, updated monthly, and undergo routine quality reviews to verify accuracy. For the purpose of this study, the percentage of change in the Hb level was defined as (first-nadir Hb)/first Hb × 100, and the transfusion trigger was defined as the lowest measured Hb (nadir Hb) in the patients who received a PRBC transfusion during hospitalization. 5, 7, 8 The cutoff used for ΔHb (50% decrease) and nadir Hb levels (<7 g/dL) was based on the previous findings from patients undergoing cardiac surgery.
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Statistical Analysis
Continuous variables were presented as mean (SD) Multivariable-adjusted logistic regression models were used to examine the effect of preoperative factors associated with ΔHb and the associations of ΔHb with perioperative morbidity, with results reported as odds ratios (ORs) (95% CIs). Analyses were further adjusted for PRBC transfusion to observe the effect of Hb level changes independent of this factor. Variations in ΔHb levels according to important potential effect modifiers were studied. To evaluate the factors associated with adverse outcomes related to PRBC transfusion, a planned subanalysis of patients who received at least 1 U of PRBC was also performed. Two-tailed P < .05 was considered statistically significant. All analyses were conducted in SAS, version 9.4 (SAS Institute Inc). 
Results
Study Population and Baseline Characteristics
Factors Associated With 50% or Greater ΔHb Levels
The effect of different preoperative factors on a decreased ΔHb level of 50% or more for patients undergoing hepatopancreaticobiliary and colorectal surgery was then evaluated. On univariable analysis, male patients (OR, 1.81; 95% CI, 1.30-2.51; P < .001), patients with multiple comorbidities (ASA 3-4: OR, 1.77; 95% CI, 1.21-2.61; P = .004; ≥3 coexisting medical conditions: OR, 1.47; 95% CI, 1.05-2.06; P = .03), and patients who underwent a pancreatic resection (OR, 1.65; 95% CI, 1.00-2.71; P = .049) were at an increased risk of having a ΔHb level of 50% or greater ( Table 1) . After adjusting for competing risk factors on multivariable analysis, patients with an ASA classification of 3 or 4 (OR, 1.96; 95% CI, 1.30-2.97; P < .001), 3 or more coexisting medical conditions (OR, 1.62; 95% CI, 1.08-2.42; P = .02), and pancreatic resection (OR, 1.98; 95% CI, 1.18-3.33; P = .01) remained independently associated with a higher risk of experiencing a ΔHb level of 50% or greater.
Association of ΔHb Level With Perioperative Morbidity
Morbidity associated with different combinations of ΔHb and nadir Hb levels is shown in Figure 1 . Of the patients with an Hb level of 7 g/dL or greater, those with a ΔHb level of 50% or more were at higher risk of complications (P < .001).
The effect of different clinicopathological factors on the morbidity of patients undergoing pancreatic, hepatic, and colorectal surgery was then analyzed ( Table 2 ). On the univariable analysis, the following factors were associated with increased risk of postoperative complications: an age of 65 years or older, male sex, an ASA classification of 3 or 4, a Charlson comorbidity index score of 3 or higher, 3 or more coexisting medical conditions, colorectal and pancreatic surgery, receipt of a transfusion, and the patient's first Hb level (Table 2 and Figure 2 ). After adjusting for demographic, clinical, and pathological characteristics, different combinations of ΔHb and nadir Hb levels were evaluated. Compared with patients who did not experience a ΔHb level of 50% or greater and had a nadir Hb level of 7 g/dL or higher (reference group) ( Of the patients who received PRBC transfusions, those who had a ΔHb level of 50% or greater were more likely to experience postoperative complications independent of the nadir Hb level. Specifically, patients with a ΔHb level of 50% or greater whose nadir Hb level was less than 7 g/dL were almost 3 times more likely to experience complications vs patients with a ΔHb level of less than 50% and a nadir Hb level of 7 g/dL or greater (OR, 2.92; 95% CI, 1.84-4.64; P < .001) ( Table 2 ). Patients with a ΔHb level of 50% or greater whose nadir Hb level remained at 7 g/dL or higher were more than 2 times more likely to experience a postoperative complication vs patients with a ΔHb level of less than 50% and an Hb level of 7 g/dL or higher (OR, 2.29; 95% CI, 1.18-4.47; P = .02). In addition, patients with a ΔHb level of less than 50% and a nadir Hb level of less than 7 g/dL were also at higher risk of morbidity (OR, 2.11; 95% CI, 1.58-2.80; P < .001).
Finally, the effect of a decrease in the Hb level and nadir Hb level on ischemic complications was evaluated ( Table 3) . Both a ΔHb level of 50% or greater (OR, 5.53; 95% CI, 2.28-13.41; P < .001) and an Hb level of less than 7 g/dL (OR, 4.77; 95% CI, 2.42-9.39; P < .001) were associated with anemia-related complications (Table 3) . Compared with patients who had a ΔHb level of less than 50% and a nadir Hb level of 7 g/dL or greater, patients who had a ΔHb level of 50% or greater had the highest risk of ischemiarelated complications, even if the nadir Hb level remained at 7 g/dL or greater (OR, 5.68; 95% CI, 1.44-22.39; P = .01). In addition, of the patients who received at least 1 U of PRBC, only patients who had a ΔHb level of 50% or greater and whose nadir HB level was less than 7 g/dL were at higher risk of anemia-related complications (OR, 2.87; 95% CI, 1.19-6.92; P = .02) ( Table 3) .
Discussion
Symptoms of anemia as well as intravascular volume are important parameters to consider when determining the need for PRBC transfusion to avoid anemia-related ischemic injury. Because these parameters are sometimes subjective and difficult to assess quantitatively, nadir Hb levels have been proposed and adopted at many centers as an objective measure to guide transfusion practices in patients without signs and symptoms of anemia or hemodynamic instability.
5-11 However, the exclusive use of Hb triggers to guide transfusion practices does not consider patient-specific factors such as sex, age, or the absolute change in the patient's Hb level. While data from cardiac studies have suggested that the ΔHb level was associated with the risk of postoperative morbidity and the need for transfusion, 13 to our knowledge, the ΔHb level has not been evaluated in a general surgery population. This study was important because we studied a large cohort of patients who underwent gastrointestinal surgery, including pancreatic, hepatobiliary, and colorectal procedures, and specifically defined how ΔHb relative to Hb triggers was associated with outcomes. Particular strengths of our study included the large cohort size (N = 4669) and the prospective high-quality transfusion and Hb data that were available through our institutional IMPACT Online Blood Management Business Intelligence Portal. We were able to examine patterns in Hb levels among patients and determine the use of PRBC and transfusion practices. Perhaps more important, we demonstrated that a ΔHb level of 50% or more was associated with complications, especially adverse ischemic events, even if the nadir Hb level remained higher than 7 g/dL. Several factors may be associated with changes in the Hb level, including operative blood loss and the amount of crystalloid administered in the perioperative period. 5, 6 We noted that factors associated with ΔHb levels included having an ASA classification of 3 or 4 and having 3 or more coexisting medical conditions. In turn, these factors were associated with an increased risk of transfusion, both among patients who had a nadir Hb level greater than 7 g/dL and those who did not. was less than 50%. These data, as well as data from 2 other studies, 12, 13 suggest that future studies investigating the relationship between transfusion strategy and perioperative outcomes should focus not only on Hb triggers but also on the change in Hb level associated with any procedure or hospital stay. The emerging emphasis on the ΔHb level is related to data suggesting that changes in the Hb level-independent of the nadir Hb level-may be associated with an increase in adverse outcomes. While van Straten and colleagues 15 have reported that the preoperative Hb level itself can predict mortality after surgery, other investigators have emphasized the importance of the change in Hb level rather than the initial Hb level. 12,13,15 Hogervorst et al 13 noted that a ΔHb level of 50% or greater during cardiac surgery was associated with adverse outcomes, even if the absolute Hb level remained higher than the commonly used transfusion threshold of 7 g/dL. Specifically, compared with patients whose Hb level remained at 7 g/dL or greater and did not decrease by 50% or more, the risk of in-hospital mortality, stroke, myocardial infarction, and renal failure was higher among patients who had an Hb level remain at 7 g/dL or greater but experienced a ΔHb level of 50% or more. 13 Karkouti and colleagues 12 similarly analyzed the degree of acute anemia that patients could safely tolerate during cardiac surgery. The authors noted that a ΔHb level of 50% or more during surgery was associated with more complications in cardiac patients. In this study, we noted that patients with a ΔHb level of 50% or greater-regardless of whether the nadir Hb level was less than 7 g/dL or 7 g/dL or greater-had a Copyright 2015 American Medical Association. All rights reserved.
5-to 6-fold higher risk of complications (Table 2) . Collectively, data from the current study, as well as from previous cardiac studies, 12, 13 Several limitations should be considered when interpreting the data. Patients in the analytic cohort were limited to individuals who did not have preexisting anemia or polycythemia and who had a preoperative Hb level of 12.0 to 16.0 g/dL (women) or 13.0 to 18.0 g/dL (men). While we used these criteria to avoid bias and to be consistent with previous cardiac studies that examined the ΔHb level, 12,13 whether our findings are generalizable to patients with preexisting anemia requires further study. In addition, perioperative morbidity data were obtained from medical record abstraction using ICD-9 codes, and thus the overall complication rate may be underestimated. However, this detection bias is likely random in nature and unlikely to have a significant effect on our overall results and conclusions. Finally, data on whether transfusion occurred intraoperatively or postoperatively were not available. The clinical decision to give a transfusion may be based on different parameters in the operating room, such as estimated blood loss and hemodynamics.
Conclusions
Our data imply that an exclusive focus on a nadir Hb level of 7 to 8 g/dL as the recommended best-practice trigger for PRBC transfusion may not always be appropriate. Future randomized clinical trials should examine the effect of both nadir Hb and ΔHb levels when investigating the association of transfusion practices with the risk of perioperative complications. expanded this concept to patients who are undergoing gastrointestinal procedures. They studied 4 groups based on whether the ΔHb level was less than 50% or 50% or greater and whether the nadir Hb level was less than 7 g/dL or 7 g/dL or greater. Patients with a nadir Hb level of 7 g/dL or greater and a ΔHb level of less than 50% rarely needed transfusions and had good outcomes. In contrast, patients with a nadir Hb level of less than 7 g/dL were frequently given transfusions and had an increased risk of adverse outcomes. The patients of interest were those who maintained a nadir Hb level of 7 g/dL or greater despite a ΔHb level of 50% or more. They had a high risk of complications but also seemed sicker at baseline than patients with a lower ΔHb level. This finding alone does not justify transfusion. A patient's ΔHb may just be a summative marker of preoperative risk factors and perioperative blood loss, yet the current data justify further study of ΔHb.
Extrapolating from this study is difficult. First, the authors could not separate transfusions in the operating room, which are often driven by blood loss without Hb levels, from postoperative transfusions. Neither the true nadirs nor the indications for transfusion are known. Second, specific data on transfusions for patients with a nadir Hb level of 7 g/dL or greater and a ΔHb level of 50% or more are lacking, but overall, transfusion was independently associated with increased morbidity. Third, the authors suggest that an indication for transfusion is the prevention of ischemic complications. We do not know if the Hb levels caused cardiac or neurologic events in some patients because these patients also had more comorbidities. Hemodynamic, blood gas, or lactate data suggesting ischemia would help us understand the effect of anemia.
Spolverato et al 5 should be commended for suggesting that factors besides Hb level, hemodynamics, or blood loss should drive transfusion decisions. As the authors suggest, individualizing transfusion decisions makes sense. Currently, clinical evidence of hemorrhage remains an appropriate indication for transfusion. Symptomatic anemia, on the other hand, is a vague indication unless the symptoms suggest cardiac or cerebral ischemia in an anemic patient. A patient's Hb level is probably not the answer; some patients need a higher value, and others may tolerate less than 7 g/dL. The best answer may be the establishment of a biomarker for inadequate oxygen delivery that would correlate with better outcomes after transfusion. There is no doubt that blood loss is bad, but not all patients who experience blood loss benefit from transfusions.
